Novavax: See Their Revenue, Competitors, Traffic, and Reviews (August 2025)

Review (August 2025)

Innovative proprietary recombinant nanoparticle vaccine technology prevents a broad range of infectious diseases

28.62M

Estimated Revenue

462.03k

Website Visitors

4/5

Trustpilot Score

What do we know about NOVAVAX INC?

Estimated Revenue (2020)

$28.62M

Total Employees

600 Founded

1987

Industry

Pharmaceuticals

Location

Gaithersburg, United States

About

NOVAVAX INC: Innovative proprietary recombinant nanoparticle vaccine technology prevents a broad range of infectious diseases

Social Links

Alexa Ranking: 197327

What is NOVAVAX INC's Revenue?

NOVAVAX INC's estimated revenue for 2024 is $28.62M.

What does NOVAVAX INC do?

Focused on creating the next generation of revolutionary vaccines. Novavax is a late-stage biotechnology company dedicated to improving health globally through the discovery, development, and commercialization of innovative vaccines. Our proprietary recombinant technology platform combines the power and speed of genetic engineering to with the immunogenicity enhancing properties of our Matrix-M™ adjuvant to efficiently produce highly immunogenic nanoparticles with the potential to address some of the most urgent global health needs. Our product pipeline targets a variety of serious infectious diseases, from influenza to emerging infectious diseases. We are developing NVX-CoV2373, a vaccine candidate against SARS-CoV-2, the virus that causes COVID-19. NanoFlu™ is our quadrivalent influenza nanoparticle vaccine, which met all primary objectives in a pivotal Phase 3 clinical trial in older adults. Both vaccine candidates incorporate Novavax' proprietary saponin-based Matrix-M™ adjuvant in order to enhance the immune response and stimulate high levels of neutralizing antibodies. Headquartered in Gaithersburg, Maryland, Novavax has additional facilities in Uppsala, Sweden and Bohumil, Czech Republic. Our employees worldwide are dedicated to developing novel vaccines to address infectious disease. Novavax is traded on NASDAQ under the symbol NVAX. Visit Novavax.com to learn more.

What are the monthly traffic metrics for Novavax?

6/mo Traffic Growth

-21.60%

All Time Traffic Growth

Create Free Account

Monthly Hits

462k

Time on Site

1.2Mins

Bounce Rate

65%

How fast is Novavax growing?

Novavax has grown by 7.4% in the last 6 months according to SimilarWeb.

How do people interact with Novavax?

Last month, Novavax received 462k visitors who spent an average of 1.2 minutes on the website and visited 1.0 different pages per session. Overall, 65% of people bounce on the first visit.

How do people find Novavax?

109.3k people (24%) visit Novavax directly. 285.2k (62%) people search for them in Google. Whereas, 30.1k (7%) discover Novavax through Facebook, Reddit, and YouTube. 1.1k (0%) visitors come from Novavax's email newsletters. Finally, 5.7 (0.0%) people come from affiliates and or paid referrals.

Who uses Novavax?

Novavax's top market is the United States and they receive 251.4k (54.4%) people.
Then the 2nd is Australia with 27.9k (6.0%).
The 3rd is is Canada with 25.8k (5.6%).

Traffic Growth (last 6 months)

All Traffic Source

Country Share

Traffic Growth (last 12 months)

See 12/mo Traffic Stats

Fashionnova

Fashion nova is the top online fashion store for women. shop sexy club dresses, jeans, shoes, bodysuits, skirts and more. cheap &amp; affordable fashion online.... More